Literature DB >> 20817884

Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy.

Katherine D Mathews1, Chris Cunniff, Jiji R Kantamneni, Emma Ciafaloni, Timothy Miller, Dennis Matthews, Valerie Cwik, Charlotte Druschel, Lisa Miller, F John Meaney, John Sladky, Paul A Romitti.   

Abstract

The Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) is a multisite collaboration to determine the prevalence of childhood-onset Duchenne/Becker muscular dystrophy and to characterize health care and health outcomes in this population. MD STARnet uses medical record abstraction to identify patients with Duchenne/Becker muscular dystrophy born January 1, 1982 or later who resided in 1 of the participating sites. Critical diagnostic elements of each abstracted record are reviewed independently by >4 clinicians and assigned to 1 of 6 case definition categories (definite, probable, possible, asymptomatic, female, not Duchenne/Becker muscular dystrophy) by consensus. As of November 2009, 815 potential cases were reviewed. Of the cases included in analysis, 674 (82%) were either ''definite'' or ''probable'' Duchenne/Becker muscular dystrophy. These data reflect a change in diagnostic testing, as case assignment based on genetic testing increased from 67% in the oldest cohort (born 1982-1987) to 94% in the cohort born 2004 to 2009.

Entities:  

Mesh:

Year:  2010        PMID: 20817884      PMCID: PMC3674568          DOI: 10.1177/0883073810371001

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  12 in total

1.  Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort.

Authors:  K M Dent; D M Dunn; A C von Niederhausern; A T Aoyagi; L Kerr; M B Bromberg; K J Hart; T Tuohy; S White; J T den Dunnen; R B Weiss; K M Flanigan
Journal:  Am J Med Genet A       Date:  2005-04-30       Impact factor: 2.802

2.  LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.

Authors:  Marianne Schwartz; Jens Michael Hertz; Marie Louise Sveen; John Vissing
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

3.  Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.

Authors:  E Bonilla; C E Samitt; A F Miranda; A P Hays; G Salviati; S DiMauro; L M Kunkel; E P Hoffman; L P Rowland
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

4.  Diagnosis of Duchenne dystrophy by enhanced detection of small mutations.

Authors:  J R Mendell; C H Buzin; J Feng; J Yan; C Serrano; D S Sangani; C Wall; T W Prior; S S Sommer
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

5.  The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology.

Authors:  Lisa A Miller; Paul A Romitti; Christopher Cunniff; Charlotte Druschel; Katherine D Mathews; F John Meaney; Dennis Matthews; Jiji Kantamneni; Zhen-Fang Feng; Nancy Zemblidge; Timothy M Miller; Jennifer Andrews; Deborah Fox; Emma Ciafaloni; Shree Pandya; April Montgomery; Aileen Kenneson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-11

6.  Mutation analysis in a population-based cohort of boys with Duchenne or Becker muscular dystrophy.

Authors:  Christopher Cunniff; Jennifer Andrews; F John Meaney; Katherine D Mathews; Dennis Matthews; Emma Ciafaloni; Timothy M Miller; John B Bodensteiner; Lisa A Miller; Katherine A James; Charlotte M Druschel; Paul A Romitti; Shree Pandya
Journal:  J Child Neurol       Date:  2008-12-12       Impact factor: 1.987

7.  Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-10-16       Impact factor: 17.586

8.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

9.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

Authors:  M Koenig; A P Monaco; L M Kunkel
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

10.  Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification.

Authors:  J S Chamberlain; R A Gibbs; J E Ranier; P N Nguyen; C T Caskey
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

View more
  43 in total

1.  Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy.

Authors:  Sarah K Nabukera; Paul A Romitti; Kimberly A Campbell; F John Meaney; Kristin M Caspers; Katherine D Mathews; Stacey M Hockett Sherlock; Soman Puzhankara; Christopher Cunniff; Charlotte M Druschel; Shree Pandya; Dennis J Matthews; Emma Ciafaloni
Journal:  J Child Neurol       Date:  2011-12-07       Impact factor: 1.987

2.  Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials.

Authors:  Jacob J Gissy; Teresa Johnson; Deborah J Fox; Anil Kumar; Emma Ciafaloni; Anthonie J van Essen; Holly L Peay; Ann Martin; Ann Lucas; Richard S Finkel
Journal:  Neuromuscul Disord       Date:  2017-07-21       Impact factor: 4.296

3.  Reproductive patterns among mothers of males diagnosed with Duchenne or Becker muscular dystrophy.

Authors:  Sarah K Nabukera; Paul A Romitti; Kristin M Caspers; Natalie Street; Christopher Cunniff; Katherine D Mathews; Deborah J Fox; Soman Puzhankara; Emma Ciafaloni; Katherine A James; Yin Su
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

4.  A novel noncontiguous duplication in the DMD gene escapes the 'reading-frame rule'.

Authors:  Luz Berenice López-Hernández; Benjamín Gómez-Díaz; Eliganty Bahena-Martínez; Teresa Neri-Gómez; Alejandra Camacho-Molina; Luis A Ruano-Calderón; Silvia García; Ramón M Coral-Vázquez
Journal:  J Genet       Date:  2014-04       Impact factor: 1.166

5.  Prevalence of Duchenne and Becker muscular dystrophies in the United States.

Authors:  Paul A Romitti; Yong Zhu; Soman Puzhankara; Katherine A James; Sarah K Nabukera; Gideon K D Zamba; Emma Ciafaloni; Christopher Cunniff; Charlotte M Druschel; Katherine D Mathews; Dennis J Matthews; F John Meaney; Jennifer G Andrews; Kristin M Caspers Conway; Deborah J Fox; Natalie Street; Melissa M Adams; Julie Bolen
Journal:  Pediatrics       Date:  2015-02-16       Impact factor: 7.124

6.  Prevalence and Genetic Profile of Duchene and Becker Muscular Dystrophy in Puerto Rico.

Authors:  Edwardo Ramos; José G Conde; Rafael Arias Berrios; Sherly Pardo; Omar Gómez; Manuel F Mas Rodríguez
Journal:  J Neuromuscul Dis       Date:  2016-05-27

Review 7.  Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data?

Authors:  Michele A Scully; Valerie A Cwik; Bruce C Marshall; Emma Ciafaloni; Jodi M Wolff; Thomas S Getchius; Robert C Griggs
Journal:  Neurology       Date:  2013-02-05       Impact factor: 9.910

8.  Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?

Authors:  Aida Soim; Michael G Smith; Jennifer M Kwon; Joshua R Mann; Shiny Thomas; Emma Ciafaloni
Journal:  J Child Neurol       Date:  2018-05-15       Impact factor: 1.987

9.  Muscular Dystrophy Surveillance, Tracking, and Research Network pilot: Population-based surveillance of major muscular dystrophies at four U.S. sites, 2007-2011.

Authors:  ThuyQuynh N Do; Natalie Street; Jennifer Donnelly; Melissa M Adams; Christopher Cunniff; Deborah J Fox; Richard O Weinert; Joyce Oleszek; Paul A Romitti; Christina P Westfield; Julie Bolen
Journal:  Birth Defects Res       Date:  2018-08-02       Impact factor: 2.344

10.  Bone Health and Endocrine Care of Boys with Duchenne Muscular Dystrophy: Data from the MD STARnet.

Authors:  David R Weber; Shiny Thomas; Stephen W Erickson; Deborah Fox; Joyce Oleszek; Shree Pandya; Yedatore Venkatesh; Christina Westfield; Emma Ciafaloni
Journal:  J Neuromuscul Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.